Global Market for Treatment for Syndromes of Dementia and Movement Disorders Driven by the Increasing Aging Population

Persistence Market Research (PMR) forecasts that the global market for treatment for syndromes of dementia and movement disorders will expand at a CAGR of 8.6% during the forecast period of 2014-2020. In 2014, the market was valued at US$12,859.8 million and in 2020 the market is expected to reach a value of US$21,154.8 million. Here are the key trends that will shape the growth of the global market for treatment for syndromes of dementia and movement disorders till 2020.

Read Full Report: http://www.persistencemarketresearch.com/market-research/treatment-syndromes-dementia-movement-disorders-market.asp

Market Drivers

  • Dementia is one of the primary causes of disability in the elderly population. The accelerating aging population around the world will drive the global market for treatment for syndromes of dementia and movement disorders to a great extent.

  • Due to growing geriatric population the prevalence of neurodegenerative diseases will increase significantly. This will further fuel the global market for treatment for syndromes of dementia and movement disorders.

  • The treatment of dementia and movement disorders depends on the cause of the disease. Such conditions are treated symptomatically with biological therapy and medications. The growing awareness about such mental conditions along with rising demand for its treatment around the world has resulted in elevated investment and initiatives by public and private health institutions. This will further drive the global market for treatment for syndromes of dementia and movement disorders.

  • Furthermore, the rising R&D investments in drug discovery and other related development projects will drive the global market for treatment for syndromes of dementia and movement disorders till 2020.

Market Restraints

The stringent regulatory scenario and the long approval time for drugs aimed at treating the syndromes of dementia and movement disorders will hamper the market growth. Additionally, most of the drugs tend to fail during the Phase III as there is limited knowledge about the mechanism of the brain and the unknown causes behind these diseases.

Presently, the number of collaborations and partnerships programs are growing in the global market for the treatment of syndromes of dementia and movement disorders. Several drugs to treat the symptoms of dementia and movement disorders are in the pipeline.

FORUM Pharmaceuticals’ pipeline is concentrating in the development of new treatment for important neurodegenerative disorders. Axovant Sciences is planning to develop a pipeline of product candidates that address conditions such as dementia. Biotie has one product candidate in its pipeline called SYN120 aimed to treat Parkinson’s, Alzheimer’s disease, and dementia. Some of the key players operating in the global market for treatment for syndromes of dementia and movement disorders are Novartis, Baxter, Merck & Co., Sanofi, Bristol-Myers Squibb, Abbott Laboratories, and AstraZeneca.

North America is leading the global market for treatment for syndromes of dementia and movement disorders. However, Asia Pacific is expected to emerge as the fastest growing region in the global market for treatment for syndromes of dementia and movement disorders during the forecast period. The increasing health insurance penetration in Asia Pacific as compared to the European and North American regions will drive the Asia Pacific market for treatment for syndromes of dementia and movement disorders.

Progressive dementia has registered fastest growth in the market. Alzehimer’s disease, Lewy body dementia, frontotemporal dementia are the most common types of progressive dementia.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s